E-Mail
IMAGE: A research participant wearing the BrainQ System, an AI-powered device that delivers electromagnetic stimulation to the upper extremity of individuals with impaired motor abilities. view more
Credit: BrainQ Technologies
East Hanover, NJ. January 14, 2021. Ghaith Androwis, PhD, and Steven Kirshblum, MD, received a grant from BrainQ Technologies to study a potential treatment for arm and hand dysfunction in individuals with chronic spinal cord injury. The study is titled, The safety and effectiveness of the use of a brain-computer interface-based electromagnetic field treatment in the management of patients with chronic spinal cord injury: A pilot study.
Dr. Androwis is a research scientist in the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation. Dr. Kirshblum is senior medical officer and director of the Spinal Cord Injury Program for Kessler Institute for Rehabilitation, chief academic officer for the Select Medical R
E-Mail
(Philadelphia, PA) - Like a failing fuel pump that causes a loss of engine power in a car, a diseased heart can take a serious toll on the body s performance. For some patients, tasks like walking up a flight of stairs or walking across a room eventually turn into exhausting endeavors. This is because, over time, regardless of the underlying cause, heart damage typically progresses, owing to a constant barrage of oxidative stress and toxic lipids that alter heart cell energetics and, ultimately, the ability of the heart to function normally.
Oxidative stress occurs when harmful oxygen-containing molecules outnumber helpful antioxidants, leading to damaging reactions with proteins, DNA, and other cell components. Now, in two new studies, researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) show that in the heart, one molecule in particular, Kruppel-like factor (KLF)-5, single-handedly fuels both the generation of oxidizing molecules and the accumul
By TAPINTO NEWARK STAFF
Credits: File Photo
January 11, 2021 at 2:59 PM
NEWARK, NJ University Hospital, New Jersey’s state-owned public hospital, received the top designation for its liver transplant program on Monday, distinguishing it as the leader in one-year survival rate.
The Scientific Registry of Transplant Recipients awarded the status to the University Hospital Center for Advanced Liver Diseases and Transplantation, which boasts above a 98% survival rate. The program is led by physicians at Rutgers New Jersey Medical School.
“Being ranked as a top facility by the SRTR affirms that we are one of the top liver transplant programs in the entire nation,” said Dr. Nikolaos Pyrsopoulos, Medical Director of the Liver Transplant Program at University Hospital. “The SRTR ranking broadens our profile and enhances the awareness of University Hospital, and our partners at Rutgers New Jersey Medical School, to the larger world.”
For weeks, public health experts have talked about the importance of getting vaccinated against COVID-19. And, really, you only need to glance at the latest data to see how incredibly vital this is to ending the pandemic. Hundreds of thousands of people are being diagnosed with the virus each day, and nearly 400,000 have died, with many more expected.
But it s one thing to know you should get vaccinated against COVID-19 and it s another to actually do it. And that can be a real challenge for people with a fear of needles.
Known as trypanophobia, this is a real fear that impacts about 25% of adults, according to data from the Centers for Disease Control and Prevention (CDC). The fear can be so bad that about 7% of adults actually avoid getting vaccinated because of it.